GeneQuantum Healthcare is a high-tech company that focuses on the research and development of innovative Bio-therapeutics.
GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company that focuses on the research and development of innovative Bio-therapeutics.GeneQuantum was founded in August 2013 at Suzhou Industrial Park, and has built-up a world-class bio-conjugation technology platform, focusing on developing series of next generation anti-tumor Antibody-Drug-Conjugates (ADCs) with best-in-class potential. Securing this round of financing will significantly promote the development of current ADC candidates towards IND filling in both US and China, meanwhile further expanding the company's product pipeline.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 18, 2021 | Series C | — | 3 | China Life Private Equity Investment | — | Detail |
May 7, 2019 | Series B | ¥100M | 5 | Huagai Capital | — | Detail |
Mar 27, 2017 | Series A | ¥40M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
China Life Private Equity Investment | Yes | Series C |
Huagai Capital | Yes | Series B |
Suzhou Industrial Park Assets Management | — | Series C |
PICC Capital Investment Management | — | Series C |
Beijing Changping Technology Innodevelop Group | — | Series B |
Hofan Venture | — | Series B |
Oriza Seed Capital (Oriza Yuandian) | — | Series B |
TF Capital | — | Series B |